THEPHARMANETWORK LLC – Trademark Portfolio
Entity Type: 16
THEPHARMANETWORK LLC holds 8 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 5 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 3 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include THEPHARMANETWORK and THEPHARMANETWORK, LLC. The owner is based in Montvale, NJ.
180 Simmit Avenue
Montvale, NJ 07645
Showing of trademarks Trademarks
Trademark Classifications
THEPHARMANETWORK LLC's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific and technological services; industrial analysis and research services
Advertising; business management; business administration; office functions
Frequently Asked Questions
How many trademarks does THEPHARMANETWORK LLC have?
THEPHARMANETWORK LLC has 8 U.S. trademarks filed with the USPTO. Of these, 2 registered, 3 abandoned, 3 cancelled.
What trademark classes does THEPHARMANETWORK LLC file in?
THEPHARMANETWORK LLC files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 35 (Advertising & Business). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are THEPHARMANETWORK LLC's most well-known trademarks?
THEPHARMANETWORK LLC's registered trademark portfolio includes well-known marks such as THEPHARMANETWORK and THEPHARMANETWORK, LLC. These are among 2 currently registered trademarks in the portfolio.
What is THEPHARMANETWORK LLC's trademark registration success rate?
THEPHARMANETWORK LLC has a 25% trademark registration rate, with 2 out of 8 resolved applications resulting in successful registration. Currently, 0 applications are pending review.